Tazeen Ahmed
Analyst
Bank of America
Equibles does not estimate personal net worth.
About Tazeen Ahmed
Tazeen Ahmed is recorded as Analyst at Bank of America. Tazeen Ahmed has spoken on 8 earnings calls across 6 companies, most recently for Rhythm Pharmaceuticals, Inc. on November 3, 2026. Those appearances were for Rhythm Pharmaceuticals, Inc. (RYTM), Vertex Pharmaceuticals Inc (VRTX), BioNTech SE (BNTX), Denali Therapeutics Inc. (DNLI), Sarepta Therapeutics, Inc. (SRPT) and 1 other company. The companies whose calls Tazeen Ahmed spoke on are classified in the Healthcare sector.
Tazeen Ahmed on recent calls
“I'm wondering if you could just talk a bit about the decision to run a six-month hyperphagia-focused study. Will you include BMI changes in this initial study, or will that be a separate BMI-focused study?”
“Thanks for taking my question, and also my back to Uber and Awesome for all their contributions as well. Can I just get some clarification about whether you've had any meetings with FDA on the exact path forward for a go-to support?”
“I wanted to just focus on 593 for a second. I'm sorry if I missed this in your prepared remarks, but can you share any color on what level of data you plan to share when you release it?”
“A couple on FSHD and DM1, or rather one on those, how do you think about comparing the data that you've presented so far to products that have already shown data that might be further ahead in development?”
“I wanted to ask what your thoughts are, Reshma, on the read-through from the positive iGAN study that that you provided the top line for recently onto the PMN study that you're currently running for POVI.”
Affiliation history
-
Bank of America
Analyst
Transcript header (unverified)
Current
Company network
BioNTech SE
BNTX
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-11-03
View calls and events